0000914475-13-000008.txt : 20130114 0000914475-13-000008.hdr.sgml : 20130114 20130114171656 ACCESSION NUMBER: 0000914475-13-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130110 FILED AS OF DATE: 20130114 DATE AS OF CHANGE: 20130114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OBrien Christopher Flint CENTRAL INDEX KEY: 0001343124 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 13528546 MAIL ADDRESS: STREET 1: 12790 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330525145 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-01-10 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001343124 OBrien Christopher Flint NEUROCRINE BIOSCIENCES, INC. 12780 EL CAMINO REAL SAN DIEGO CA 92130 0 1 0 0 Chief Medical Officer Stock Option 8.65 2013-01-10 4 A 0 86000 8.65 A 2013-02-10 2023-01-10 Common Stock 86000 86000 D Restricted Stock Unit 2013-01-10 4 A 0 14000 0 A Common Stock 14000 14000 D Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on February 10, 2013, an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter. Each restricted stock unit represents a contingent right to receive one share of Neurocrine Common Stock. The restricted stock units will vest annually at 1/4 of the units vesting on January 10, 2014, January 10, 2015, January 10, 2016 and January 10, 2017, respectively. Margaret E. Valeur-Jensen, By Power of Attorney 2013-01-14